Ace Cholesterol Reagent, Ace Hdl-C Reagent, Ace Ldl-C Reagent, Ace Triglycerides Reagent
Enzymatic Esterase--Oxidase, Cholesterol. 510(k) K112538, from Alfa Wassermann Diagnostic Technologies, Inc. (West Caldwell, NJ). Product code CHH, class 1.
As of Nov 20, 2026, K112538 is an FDA 510(k) held by Alfa Wassermann Diagnostic Technologies, Inc., substantially equivalent on Mar 29, 2012 after 210 days, with no recalls tied to it in FDA's recall database.
- Review time: 210 days
- Recalls: 0
ACE Cholesterol Reagent is intended for the quantitative determination of cholesterol in serum and lithium heparin plasma using the ACE and ACE Alera Clinical Chemistry Systems. Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders.
- Ace Clinical Chemistry SystemK931786 · Schiapparelli Biosystems, Inc. · Sep 21, 1993
- Ace Hdl-C ReagentK971526 · Schiapparelli Biosystems, Inc. · May 21, 1997
- Ace Ldl-C Reagent, Ldl-C Calibrator, Ldl-C ControlsK991733 · Schiapparelli Biosystems, Inc. · Jul 13, 1999
- LipidsK251091 · Truvian Health · Dec 30, 2025
- CHOLESTEROL; HDL-cholesterol ; LDL-cholesterol; TRIGLYCERIDESK232404 · Medicon Hellas S.A · Aug 9, 2024
- Cholesterol2K203597 · Abbott Ireland Diagnostics Division · Jun 30, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 1, 2011
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1175
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files